+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Pharma HUB and Patient Access Support Service Market Size, Share & Trends Analysis Report by Service Type (Program Enrollment, Treatment Navigators), Service Delivery Type, Region, and Segment Forecasts, 2024-2030

  • PDF Icon

    Report

  • 120 Pages
  • May 2024
  • Region: Global
  • Grand View Research
  • ID: 5976495
Description Jump to:
The global pharma HUB and patient access support service market size is expected to reach USD 5.7 billion by 2030, registering a CAGR of 9.9% from 2024 to 2030. The growth is attributed to the significant prevalence of rare and orphan-diseased patients requiring access to specific medicines. Furthermore, the market is driven by an emphasis on establishing a patient-centered ecosystem to provide extensive support to patients throughout their treatment and an increasing demand for tailored solutions aimed at improving patient outcomes.

The prevalence of rare diseases has fueled growth in the pharmaceutical hub and patient access support service market. It is driven by specialized treatment demand, incentives for orphan drug development, the need for patient access support due to rarity, global collaborative efforts, and an expanding market for rare disease treatments. These factors have led to increased investment, innovation, and collaboration in the pharmaceutical industry, particularly in areas related to rare disease research, development, and patient support services.

Up to 36 million people in the EU are affected by rare diseases, which encompass over 6,000 distinct conditions. While some rare diseases impact only a few patients, others can affect as many as 245,000 individuals. About 80% of these diseases have genetic roots, with 70% beginning in childhood. Furthermore, in the U.S., over 10,000 rare diseases impact more than 30 million people. Moreover, it's estimated that 6-8% of the population in India is affected by rare or ultra-rare diseases. Hence, the significant prevalence of rare diseases is expected to contribute to the market growth.

Pharmaceutical companies are prioritizing the needs of patients by creating a patient-centric ecosystem that offers services to support them throughout their therapy journey. This is due to various factors such as lack of proper training, medication non-adherence, and fear of adverse effects, or missed appointments, which can affect a patient's treatment. Patients can access relevant patient service resources and start engaging with the organization as soon as they are prescribed a particular therapy.

With advanced analytics and AI technology, patient services teams can now obtain actionable insights to cater to each patient's individual needs as they progress through their treatment journey. This tailored approach ensures that patients receive the right support at the right time, leading to better therapy outcomes. For instance, companies such as Managed Markets Insight & Technology, LLC, IQVIA, & IntegriChain are offering such solutions in order to overcome barriers to patient access.

Furthermore, the life sciences industry is adapting to the digital era by focusing on value-based care and outcome-driven models that prioritize integrated services. This shift has led to the adoption of technological advancements in integrated solutions to enhance patient access and improve healthcare outcomes. One such example is the PatientLink platform, a new enterprise SaaS by TrialCard. Launched in April 2022, PatientLink simplifies patient access and engagement with Patient Support Programs while improving adherence to medication. It is a highly configurable service that offers an omnichannel experience, enabling leaders in life sciences to meet the needs of a demanding healthcare marketplace through multi-system interoperability.

Pharma HUB And Patient Access Support Service Market Report Highlights

  • Based on service type, the program enrollment segment held the largest market share in 2023. Its growth can be attributed to growing demand for customized solutions and the increasing need to improve patient outcomes drive
  • Based on service delivery type, the integrated services segment held the largest market share in 2023. Its dominance is because the integrated solutions offer a unified platform to manage various functions such as patient access support, reimbursement assistance, and pharmacy coordination
  • North America dominated the global market with the largest revenue share in 2023. Its growth can be attributed to the rising prevalence of lifestyle-associated diseases, such as diabetes & cardiovascular disorders, growing number of clinical trial-based research, strong presence of market players in the region, and presence of developed countries, such as the U.S.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Service Type
1.1.2. Service Delivery Type
1.1.3. Regional Scope
1.1.4. Estimates and Forecast Timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. Internal Database
1.3.3. Secondary Sources
1.3.4. Primary Research
1.3.5. Details of Primary Research
1.4. Information or Data Analysis
1.4.1. Data Analysis Models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity Flow Analysis (Model 1)
1.6.2. Approach 1: Commodity Flow Approach
1.6.3. Volume Price Analysis (Model 2)
1.6.4. Approach 2: Volume Price Analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Service Type Outlook
2.2.2. Service Delivery Type Outlook
2.2.3. Regional Outlook
2.3. Competitive Insights
Chapter 3. Pharma HUb and Patient Access Support Service Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Pharma HUb and Patient Access Support Service Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrant
3.3.1.5. Competitive Rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political & Legal Landscape
3.3.2.2. Economic Landscape
3.3.2.3. Social & Environmental Landscape
3.3.2.4. Technological Landscape
3.3.3. Impact of COVID-19
Chapter 4. Pharma HUb and Patient Access Support Service Market: Service Type Estimates & Trend Analysis
4.1. Service Type Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Global Pharma HUb and Patient Access Support Service Market by Service Type Outlook
4.4. Program Enrollment
4.4.1. Market Estimates and Forecast 2018 to 2030 (USD Million)
4.4.2. Order Processing
4.4.2.1. Market Estimates and Forecast 2018 to 2030 (USD Million)
4.4.3. Application Processing
4.4.3.1. Market Estimates and Forecast 2018 to 2030 (USD Million)
4.4.4. Ease of Enrollment (through Phone, Face, Portal, or App)
4.4.4.1. Market Estimates and Forecast 2018 to 2030 (USD Million)
4.4.5. Program Data
4.4.5.1. Market Estimates and Forecast 2018 to 2030 (USD Million)
4.5. Treatment Navigators
4.5.1. Market Estimates and Forecast 2018 to 2030 (USD Million)
4.5.2. Process Flows and Standard Operating Procedures
4.5.2.1. Market Estimates and Forecast 2018 to 2030 (USD Million)
4.5.3. Program Literature and Scripts
4.5.3.1. Market Estimates and Forecast 2018 to 2030 (USD Million)
4.5.4. Care Team Training
4.5.4.1. Market Estimates and Forecast 2018 to 2030 (USD Million)
4.5.5. Systems Testing and Optimization
4.5.5.1. Market Estimates and Forecast 2018 to 2030 (USD Million)
4.6. Reimbursement Services/Affordability Services
4.6.1. Market Estimates and Forecast 2018 to 2030 (USD Million)
4.7. Clinical Educator
4.7.1. Market Estimates and Forecast 2018 to 2030 (USD Million)
4.8. Coordination of Specialty Pharmacy/Dispensing
4.8.1. Market Estimates and Forecast 2018 to 2030 (USD Million)
4.9. Others
4.9.1. Market Estimates and Forecast 2018 to 2030 (USD Million)
Chapter 5. Pharma HUb and Patient Access Support Service Market: Service Delivery Type Estimates & Trend Analysis
5.1. Service Delivery Type Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Global Pharma HUb and Patient Access Support Service Market by Service Delivery Type Outlook
5.4. Integrated Services
5.4.1. Market Estimates and Forecast 2018 to 2030 (USD Million)
5.5. Standalone Services
5.5.1. Market Estimates and Forecast 2018 to 2030 (USD Million)
Chapter 6. Pharma HUb and Patient Access Support Service Market: Regional Estimates & Trend Analysis, by Service Type, by Service Delivery Type
6.1. Regional Market Share Analysis, 2023 & 2030
6.2. Regional Market Dashboard
6.3. Global Regional Market Snapshot
6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
6.5. North America
6.5.1. U.S.
6.5.1.1. Key Country Dynamics
6.5.1.2. Regulatory Framework/Reimbursement Structure
6.5.1.3. Competitive Scenario
6.5.1.4. U.S. Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.5.2. Canada
6.5.2.1. Key Country Dynamics
6.5.2.2. Regulatory Framework/Reimbursement Structure
6.5.2.3. Competitive Scenario
6.5.2.4. Canada Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.6. Europe
6.6.1. UK
6.6.1.1. Key Country Dynamics
6.6.1.2. Regulatory Framework/Reimbursement Structure
6.6.1.3. Competitive Scenario
6.6.1.4. UK Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.6.2. Germany
6.6.2.1. Key Country Dynamics
6.6.2.2. Regulatory Framework/Reimbursement Structure
6.6.2.3. Competitive Scenario
6.6.2.4. Germany Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.6.3. France
6.6.3.1. Key Country Dynamics
6.6.3.2. Regulatory Framework/Reimbursement Structure
6.6.3.3. Competitive Scenario
6.6.3.4. France Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.6.4. Italy
6.6.4.1. Key Country Dynamics
6.6.4.2. Regulatory Framework/Reimbursement Structure
6.6.4.3. Competitive Scenario
6.6.4.4. Italy Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.6.5. Spain
6.6.5.1. Key Country Dynamics
6.6.5.2. Regulatory Framework/Reimbursement Structure
6.6.5.3. Competitive Scenario
6.6.5.4. Spain Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.6.6. Denmark
6.6.6.1. Key Country Dynamics
6.6.6.2. Regulatory Framework/Reimbursement Structure
6.6.6.3. Competitive Scenario
6.6.6.4. Denmark Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.6.7. Sweden
6.6.7.1. Key Country Dynamics
6.6.7.2. Regulatory Framework/Reimbursement Structure
6.6.7.3. Competitive Scenario
6.6.7.4. Sweden Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.6.8. Norway
6.6.8.1. Key Country Dynamics
6.6.8.2. Regulatory Framework/Reimbursement Structure
6.6.8.3. Competitive Scenario
6.6.8.4. Norway Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.7. Asia-Pacific
6.7.1. Japan
6.7.1.1. Key Country Dynamics
6.7.1.2. Regulatory Framework/Reimbursement Structure
6.7.1.3. Competitive Scenario
6.7.1.4. Japan Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.7.2. China
6.7.2.1. Key Country Dynamics
6.7.2.2. Regulatory Framework/Reimbursement Structure
6.7.2.3. Competitive Scenario
6.7.2.4. China Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.7.3. India
6.7.3.1. Key Country Dynamics
6.7.3.2. Regulatory Framework/Reimbursement Structure
6.7.3.3. Competitive Scenario
6.7.3.4. India Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.7.4. Australia
6.7.4.1. Key Country Dynamics
6.7.4.2. Regulatory Framework/Reimbursement Structure
6.7.4.3. Competitive Scenario
6.7.4.4. Australia Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.7.5. South Korea
6.7.5.1. Key Country Dynamics
6.7.5.2. Regulatory Framework/Reimbursement Structure
6.7.5.3. Competitive Scenario
6.7.5.4. South Korea Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.7.6. Thailand
6.7.6.1. Key Country Dynamics
6.7.6.2. Regulatory Framework/Reimbursement Structure
6.7.6.3. Competitive Scenario
6.7.6.4. Singapore Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.8. Latin America
6.8.1. Brazil
6.8.1.1. Key Country Dynamics
6.8.1.2. Regulatory Framework/Reimbursement Structure
6.8.1.3. Competitive Scenario
6.8.1.4. Brazil Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.8.2. Mexico
6.8.2.1. Key Country Dynamics
6.8.2.2. Regulatory Framework/Reimbursement Structure
6.8.2.3. Competitive Scenario
6.8.2.4. Mexico Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.8.3. Argentina
6.8.3.1. Key Country Dynamics
6.8.3.2. Regulatory Framework/Reimbursement Structure
6.8.3.3. Competitive Scenario
6.8.3.4. Argentina Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.9. MEA
6.9.1. South Africa
6.9.1.1. Key Country Dynamics
6.9.1.2. Regulatory Framework/Reimbursement Structure
6.9.1.3. Competitive Scenario
6.9.1.4. South Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.9.2. Saudi Arabia
6.9.2.1. Key Country Dynamics
6.9.2.2. Regulatory Framework/Reimbursement Structure
6.9.2.3. Competitive Scenario
6.9.2.4. Saudi Arabia Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.9.3. UAE
6.9.3.1. Key Country Dynamics
6.9.3.2. Regulatory Framework/Reimbursement Structure
6.9.3.3. Competitive Scenario
6.9.3.4. UAE Market Estimates and Forecasts 2018 to 2030 (USD Million)
6.9.4. Kuwait
6.9.4.1. Key Country Dynamics
6.9.4.2. Regulatory Framework/Reimbursement Structure
6.9.4.3. Competitive Scenario
6.9.4.4. Kuwait Market Estimates and Forecasts 2018 to 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, by Key Market Participants
7.2. Company/Competition Categorization
7.2.1. Innovators
7.2.2. List of Key Distributors and Channel Partners
7.2.3. Key Customers
7.2.4. Key Company Market Share Analysis, 2023
7.2.5. PharmaCord
7.2.5.1. Company Overview
7.2.5.2. Financial Performance
7.2.5.3. Product Benchmarking
7.2.5.4. Strategic Initiatives
7.2.6. Fortrea
7.2.6.1. Company Overview
7.2.6.2. Financial Performance
7.2.6.3. Product Benchmarking
7.2.6.4. Strategic Initiatives
7.2.7. AssistRx
7.2.7.1. Company Overview
7.2.7.2. Financial Performance
7.2.7.3. Product Benchmarking
7.2.7.4. Strategic Initiatives
7.2.8. CareMetx
7.2.8.1. Company Overview
7.2.8.2. Financial Performance
7.2.8.3. Product Benchmarking
7.2.8.4. Strategic Initiatives
7.2.9. ConnectiveRx
7.2.9.1. Company Overview
7.2.9.2. Financial Performance
7.2.9.3. Product Benchmarking
7.2.9.4. Strategic Initiatives
7.2.10. Lash Group
7.2.10.1. Company Overview
7.2.10.2. Financial Performance
7.2.10.3. Product Benchmarking
7.2.10.4. Strategic Initiatives
7.2.11. McKesson
7.2.11.1. Company Overview
7.2.11.2. Financial Performance
7.2.11.3. Product Benchmarking
7.2.11.4. Strategic Initiatives
7.2.12. Inizio Engage
7.2.12.1. Company Overview
7.2.12.2. Financial Performance
7.2.12.3. Product Benchmarking
7.2.12.4. Strategic Initiatives
7.2.13. NS Pharma, Inc. (a Wholly Owned Subsidiary of Nippon Shinyaku Co., Ltd.)
7.2.13.1. Company Overview
7.2.13.2. Financial Performance
7.2.13.3. Product Benchmarking
7.2.13.4. Strategic Initiatives
7.2.14. Sonexus Health (acquired by Cardinal Health)
7.2.14.1. Company Overview
7.2.14.2. Financial Performance
7.2.14.3. Product Benchmarking
7.2.14.4. Strategic Initiatives
7.2.15. Envoy Health Management, LLC (independently Operated Subsidiary of Diplomat Pharmacy, Inc.)
7.2.15.1. Company Overview
7.2.15.2. Financial Performance
7.2.15.3. Product Benchmarking
7.2.15.4. Strategic Initiatives
7.2.16. EVERSANA
7.2.16.1. Company Overview
7.2.16.2. Financial Performance
7.2.16.3. Product Benchmarking
7.2.16.4. Strategic Initiatives
7.2.17. United BioSource LLC (UBC)
7.2.17.1. Company Overview
7.2.17.2. Financial Performance
7.2.17.3. Product Benchmarking
7.2.17.4. Strategic Initiatives
7.2.18. Mercalis
7.2.18.1. Company Overview
7.2.18.2. Financial Performance
7.2.18.3. Product Benchmarking
7.2.18.4. Strategic Initiatives
List of Tables
Table 1 List of Abbreviation
Table 2 North America Pharma HUb and Patient Access Support Service Market, by Region, 2018-2030 (USD Million)
Table 3 North America Pharma HUb and Patient Access Support Service Market, by Service Type, 2018-2030 (USD Million)
Table 4 North America Pharma HUb and Patient Access Support Service Market, by Service Delivery Type, 2018-2030 (USD Million)
Table 5 U.S. Pharma HUb and Patient Access Support Service Market, by Service Type, 2018-2030 (USD Million)
Table 6 U.S. Pharma HUb and Patient Access Support Service Market, by Service Delivery Type, 2018-2030 (USD Million)
Table 7 Canada Pharma HUb and Patient Access Support Service Market, by Service Type, 2018-2030 (USD Million)
Table 8 Canada Pharma HUb and Patient Access Support Service Market, by Service Delivery Type, 2018-2030 (USD Million)
Table 9 Europe Pharma HUb and Patient Access Support Service Market, by Region, 2018-2030 (USD Million)
Table 10 Europe Pharma HUb and Patient Access Support Service Market, by Service Type, 2018-2030 (USD Million)
Table 11 Europe Pharma HUb and Patient Access Support Service Market, by Service Delivery Type, 2018-2030 (USD Million)
Table 12 Germany Pharma HUb and Patient Access Support Service Market, by Service Type, 2018-2030 (USD Million)
Table 13 Germany Pharma HUb and Patient Access Support Service Market, by Service Delivery Type, 2018-2030 (USD Million)
Table 14 UK Pharma HUb and Patient Access Support Service Market, by Service Type, 2018-2030 (USD Million)
Table 15 UK Pharma HUb and Patient Access Support Service Market, by Service Delivery Type, 2018-2030 (USD Million)
Table 16 France Pharma HUb and Patient Access Support Service Market, by Service Type, 2018-2030 (USD Million)
Table 17 France Pharma HUb and Patient Access Support Service Market, by Service Delivery Type, 2018-2030 (USD Million)
Table 18 Italy Pharma HUb and Patient Access Support Service Market, by Service Type, 2018-2030 (USD Million)
Table 19 Italy Pharma HUb and Patient Access Support Service Market, by Service Delivery Type, 2018-2030 (USD Million)
Table 20 Spain Pharma HUb and Patient Access Support Service Market, by Service Type, 2018-2030 (USD Million)
Table 21 Spain Pharma HUb and Patient Access Support Service Market, by Service Delivery Type, 2018-2030 (USD Million)
Table 22 Denmark Pharma HUb and Patient Access Support Service Market, by Service Type, 2018-2030 (USD Million)
Table 23 Denmark Pharma HUb and Patient Access Support Service Market, by Service Delivery Type, 2018-2030 (USD Million)
Table 24 Sweden Pharma HUb and Patient Access Support Service Market, by Service Type, 2018-2030 (USD Million)
Table 25 Sweden Pharma HUb and Patient Access Support Service Market, by Service Delivery Type, 2018-2030 (USD Million)
Table 26 Norway Pharma HUb and Patient Access Support Service Market, by Service Type, 2018-2030 (USD Million)
Table 27 Norway Pharma HUb and Patient Access Support Service Market, by Service Delivery Type, 2018-2030 (USD Million)
Table 28 Asia-Pacific Pharma HUb and Patient Access Support Service Market, by Region, 2018-2030 (USD Million)
Table 29 Asia-Pacific Pharma HUb and Patient Access Support Service Market, by Service Type, 2018-2030 (USD Million)
Table 30 Asia-Pacific Pharma HUb and Patient Access Support Service Market, by Service Delivery Type, 2018-2030 (USD Million)
Table 31 China Pharma HUb and Patient Access Support Service Market, by Service Type, 2018-2030 (USD Million)
Table 32 China Pharma HUb and Patient Access Support Service Market, by Service Delivery Type, 2018-2030 (USD Million)
Table 33 Japan Pharma HUb and Patient Access Support Service Market, by Service Type, 2018-2030 (USD Million)
Table 34 Japan Pharma HUb and Patient Access Support Service Market, by Service Delivery Type, 2018-2030 (USD Million)
Table 35 India Pharma HUb and Patient Access Support Service Market, by Service Type, 2018-2030 (USD Million)
Table 36 South Korea Pharma HUb and Patient Access Support Service Market, by Service Type, 2018-2030 (USD Million)
Table 37 South Korea Pharma HUb and Patient Access Support Service Market, by Service Delivery Type, 2018-2030 (USD Million)
Table 38 Australia Pharma HUb and Patient Access Support Service Market, by Service Type, 2018-2030 (USD Million)
Table 39 Australia Pharma HUb and Patient Access Support Service Market, by Service Delivery Type, 2018-2030 (USD Million)
Table 40 Thailand Pharma HUb and Patient Access Support Service Market, by Service Type, 2018-2030 (USD Million)
Table 41 Thailand Pharma HUb and Patient Access Support Service Market, by Service Delivery Type, 2018-2030 (USD Million)
Table 42 Latin America Pharma HUb and Patient Access Support Service Market, by Region, 2018-2030 (USD Million)
Table 43 Latin America Pharma HUb and Patient Access Support Service Market, by Service Type, 2018-2030 (USD Million)
Table 44 Latin America Pharma HUb and Patient Access Support Service Market, by Service Delivery Type, 2018-2030 (USD Million)
Table 45 Brazil Pharma HUb and Patient Access Support Service Market, by Service Type, 2018-2030 (USD Million)
Table 46 Brazil Pharma HUb and Patient Access Support Service Market, by Service Delivery Type, 2018-2030 (USD Million)
Table 47 Mexico Pharma HUb and Patient Access Support Service Market, by Service Type, 2018-2030 (USD Million)
Table 48 Mexico Pharma HUb and Patient Access Support Service Market, by Service Delivery Type, 2018-2030 (USD Million)
Table 49 Argentina Pharma HUb and Patient Access Support Service Market, by Service Type, 2018-2030 (USD Million)
Table 50 Argentina Pharma HUb and Patient Access Support Service Market, by Service Delivery Type, 2018-2030 (USD Million)
Table 51 MEA Pharma HUb and Patient Access Support Service Market, by Region, 2018-2030 (USD Million)
Table 52 MEA Pharma HUb and Patient Access Support Service Market, by Service Type, 2018-2030 (USD Million)
Table 53 MEA Pharma HUb and Patient Access Support Service Market, by Service Delivery Type, 2018-2030 (USD Million)
Table 54 South Africa Pharma HUb and Patient Access Support Service Market, by Service Type, 2018-2030 (USD Million)
Table 55 South Africa Pharma HUb and Patient Access Support Service Market, by Service Delivery Type, 2018-2030 (USD Million)
Table 56 Saudi Arabia Pharma HUb and Patient Access Support Service Market, by Service Type, 2018-2030 (USD Million)
Table 57 Saudi Arabia Pharma HUb and Patient Access Support Service Market, by Service Delivery Type, 2018-2030 (USD Million)
Table 58 UAE Pharma HUb and Patient Access Support Service Market, by Service Type, 2018-2030 (USD Million)
Table 59 UAE Pharma HUb and Patient Access Support Service Market, by Service Delivery Type, 2018-2030 (USD Million)
Table 60 Kuwait Pharma HUb and Patient Access Support Service Market, by Service Type, 2018-2030 (USD Million)
Table 61 Kuwait Pharma HUb and Patient Access Support Service Market, by Service Delivery Type, 2018-2030 (USD Million)
List of Figures
Figure 1 Market Research Process
Figure 2 Data Triangulation Techniques
Figure 3 Primary Research Pattern
Figure 4 Market Research Approaches
Figure 5 Value-chain-based Sizing & Forecasting
Figure 6 QFD Modeling for Market Share Assessment
Figure 7 Market Formulation & Validation
Figure 8 Pharma HUb and Patient Access Support Service Market: Market Outlook
Figure 9 Credentialing Software and Services Competitive Insights
Figure 10 Parent Market Outlook
Figure 11 Related/ancillary Market Outlook
Figure 12 Penetration and Growth Prospect Mapping
Figure 13 Industry Value Chain Analysis
Figure 14 Pharma HUb and Patient Access Support Service Market Driver Impact
Figure 15 Pharma HUb and Patient Access Support Service Market Restraint Impact
Figure 16 Pharma HUb and Patient Access Support Service Market Strategic Initiatives Analysis
Figure 17 Pharma HUb and Patient Access Support Service Market: Service Type Movement Analysis
Figure 18 Pharma HUb and Patient Access Support Service Market: Service Type Outlook and Key Takeaways
Figure 19 Program Enrollment Market Estimates and Forecast, 2018-2030
Figure 20 Order Processing Market Estimates and Forecast, 2018-2030
Figure 21 Application Processing Market Estimates and Forecast, 2018-2030
Figure 22 Ease of Enrollment (through Phone, Face, Portal, or App) Market Estimates and Forecast, 2018-2030
Figure 23 Program Data Market Estimates and Forecast, 2018-2030
Figure 24 Treatment Navigators Market Estimates and Forecast, 2018-2030
Figure 25 Process Flows and Standard Operating Procedures Market Estimates and Forecast, 2018-2030
Figure 26 Program Literature and Scripts Market Estimates and Forecast, 2018-2030
Figure 27 Care Team Training Market Estimates and Forecast, 2018-2030
Figure 28 Systems Testing and Optimization Market Estimates and Forecast, 2018-2030
Figure 29 Reimbursement Services/affordability Services Market Estimates and Forecast, 2018-2030
Figure 30 Clinical Educator Market Estimates and Forecast, 2018-2030
Figure 31 Coordination of Specialty Pharmacy/dispensing Market Estimates and Forecast, 2018-2030
Figure 32 Others Market Estimates and Forecast, 2018-2030
Figure 33 Pharma HUb and Patient Access Support Service Market: Service Delivery Type Movement Analysis
Figure 34 Pharma HUb and Patient Access Support Service Market: Service Delivery Type Outlook and Key Takeaways
Figure 35 Integrated Services Market Estimates and Forecast, 2018-2030
Figure 36 Standalone Services Market Estimates and Forecast, 2018-2030
Figure 37 Pharma HUb and Patient Access Support Service Market: Regional Movement Analysis
Figure 38 Pharma HUb and Patient Access Support Service Market: Regional Outlook and Key Takeaways
Figure 39 Pharma HUb and Patient Access Support Service Market Share and Leading Players
Figure 40 North America Market Share and Leading Players
Figure 41 Europe Market Share and Leading Players
Figure 42 Asia-Pacific Market Share and Leading Players
Figure 43 Latin America Market Share and Leading Players
Figure 44 Middle East & Africa Market Share and Leading Players
Figure 45 North America: SWOT
Figure 46 Europe SWOT
Figure 47 Asia-Pacific SWOT
Figure 48 Latin America SWOT
Figure 49 MEA SWOT
Figure 50 North America, by Country
Figure 51 North America
Figure 52 North America Market Estimates and Forecasts, 2018-2030
Figure 53 U.S.
Figure 54 U.S. Market Estimates and Forecasts, 2018-2030
Figure 55 Canada
Figure 56 Canada Market Estimates and Forecasts, 2018-2030
Figure 57 Europe
Figure 58 Europe Market Estimates and Forecasts, 2018-2030
Figure 59 UK
Figure 60 UK Market Estimates and Forecasts, 2018-2030
Figure 61 Germany
Figure 62 Germany Market Estimates and Forecasts, 2018-2030
Figure 63 France
Figure 64 France Market Estimates and Forecasts, 2018-2030
Figure 65 Italy
Figure 66 Italy Market Estimates and Forecasts, 2018-2030
Figure 67 Spain
Figure 68 Spain Market Estimates and Forecasts, 2018-2030
Figure 69 Denmark
Figure 70 Denmark Market Estimates and Forecasts, 2018-2030
Figure 71 Sweden
Figure 72 Sweden Market Estimates and Forecasts, 2018-2030
Figure 73 Norway
Figure 74 Norway Market Estimates and Forecasts, 2018-2030
Figure 75 Asia-Pacific
Figure 76 Asia-Pacific Market Estimates and Forecasts, 2018-2030
Figure 77 China
Figure 78 China Market Estimates and Forecasts, 2018-2030
Figure 79 Japan
Figure 80 Japan Market Estimates and Forecasts, 2018-2030
Figure 81 India
Figure 82 India Market Estimates and Forecasts, 2018-2030
Figure 83 Thailand
Figure 84 Thailand Market Estimates and Forecasts, 2018-2030
Figure 85 South Korea
Figure 86 South Korea Market Estimates and Forecasts, 2018-2030
Figure 87 Australia
Figure 88 Australia Market Estimates and Forecasts, 2018-2030
Figure 89 Latin America
Figure 90 Latin America Market Estimates and Forecasts, 2018-2030
Figure 91 Brazil
Figure 92 Brazil Market Estimates and Forecasts, 2018-2030
Figure 93 Mexico
Figure 94 Mexico Market Estimates and Forecasts, 2018-2030
Figure 95 Argentina
Figure 96 Argentina Market Estimates and Forecasts, 2018-2030
Figure 97 Middle East and Africa
Figure 98 Middle East and Africa Market Estimates and Forecasts, 2018-2030
Figure 99 South Africa
Figure 100 South Africa Market Estimates and Forecasts, 2018-2030
Figure 101 Saudi Arabia
Figure 102 Saudi Arabia Market Estimates and Forecasts, 2018-2030
Figure 103 UAE
Figure 104 UAE Market Estimates and Forecasts, 2018-2030
Figure 105 Kuwait
Figure 106 Kuwait Market Estimates and Forecasts, 2018-2030
Figure 107 Market Share of Key Market Players- Pharma HUb and Patient Access Support Service Market

Companies Mentioned

  • PharmaCord
  • Fortrea
  • AssistRx
  • CareMetx
  • ConnectiveRx
  • Lash Group
  • McKesson
  • Inizio Engage
  • NS Pharma, Inc. (a wholly owned subsidiary of Nippon Shinyaku Co., Ltd.)
  • Sonexus Health (acquired by Cardinal Health)
  • Envoy Health Management, LLC (independently operated subsidiary of Diplomat Pharmacy, Inc.)
  • EVERSANA
  • United BioSource LLC (UBC)
  • Mercalis

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages120
PublishedMay 2024
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 3 Billion
Forecasted Market Value ( USD ) by 2030 $ 5.7 Billion
Compound Annual Growth Rate9.9%
Regions CoveredGlobal
No. of Companies Mentioned14

Related Topics

Related Reports

Pharma 4.0 Market Size, Share & Trends Analysis Report By Type (Software, Services), By Technology (AI/ML, Big Data Analytics, IoT, Blockchain Technology), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Pharma 4.0 Market Size, Share & Trends Analysis Report By Type (Software, Services), By Technology (AI/ML, Big Data Analytics, IoT, Blockchain Technology), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 150 Pages
  • Global
From
Pharma E-Commerce Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Image

Pharma E-Commerce Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • 150 Pages
  • Global
From
Pharmerging - Global Strategic Business Report - Product Image

Pharmerging - Global Strategic Business Report

  • Report
  • 184 Pages
  • Global
From
AI in Pharma Global Market Report 2024 - Product Image

AI in Pharma Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Pharmaceutical Suppositories Global Market Report 2024 - Product Image

Pharmaceutical Suppositories Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.